Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Avidity completes venture financing

    Avidity raised $10 million in a series B round led by Takeda Ventures. Alethea Capital Management, Alexandria Real Estate Equities, Brace Pharma Capital, EcoR1 Capital, F-Prime Capital, Moore Venture Partners and …

    Published on 1/9/2017
  • BiondVax completes private placement

    BiondVax raised NIS10.9 million ($2.8 million) through the sale of 33.8 million shares at NIS0.32 in a private placement with Angels High Tech Investments.BiondVax Pharmaceuticals Ltd. (Tel Aviv:BVXV; NASDAQ:BVXV), Ness…

    Published on 1/9/2017
  • BlackThorn completes venture financing

    BlackThorn raised $14 million in an extension of a series A round, bringing the total raised in the round to $54 million. New investors GV and Biomatics Capital participated in the extension.BlackThorn Therapeutics Inc…

    Published on 1/9/2017
  • Cavion completes venture financing

    Cavion raised $26.1 million in a series A round co-led by Lilly Ventures and Novartis Venture Fund. Enso Ventures and existing investors also participated.Cavion Inc., Charlottesville, Va.

    Published on 1/9/2017
  • Clovis completes follow-on

    Clovis raised $235.8 million through the sale of 5.8 million shares at $41 in a follow-on underwritten by JPMorgan, BofA Merrill Lynch, Stifel and SunTrust. The figures include the sale of a 750,000 share overallotment.…

    Published on 1/9/2017
  • Crown completes IPO

    Crown raised NT$731.9 million ($23 million) through the sale of 13.1 million shares at NT$55.78 in an IPO underwritten by Yuanta Securities and KGI Securities.Crown Bioscience International Inc. (TPEx:6554), Taipei, …

    Published on 1/9/2017
  • Eiger completes debt financing

    Eiger drew down $15 million from a new $25 million debt financing from Oxford Finance. Eiger may draw down the remaining $10 million subject to development milestones. The loans mature on July 1, 2021, and bear a …

    Published on 1/9/2017
  • F1 Oncology completes venture financing

    F1 Oncology raised $37 million in a series A round from F1 BioVentures, Sinobioway Group and SunTerra Capital.F1 Oncology Inc., West Palm Beach, Fla.

    Published on 1/9/2017
  • Frontier Biotechnologies completes venture financing

    Frontier raised RMB300 million ($43.2 million) in a series C round led by Huaxin Century Investment Group. Shenzhen Capital Group, EFung Capital and undisclosed investors also participated.Frontier Biotechnologies Co. …

    Published on 1/9/2017
  • Interpace Diagnostics completes direct public offering

    Interpace raised $4.3 million through the sale of 630,000 shares at $6.81 in a direct public offering with institutional investors. Maxim Group was the placement agent.Interpace Diagnostics Group Inc. (NASDAQ:IDXG), …

    Published on 1/9/2017
  • Jupiter completes venture financing

    Jupiter raised $1 million through the sale of a convertible note to Tarnagulla Ventures. Jupiter may receive an additional $1 million subject to milestones. The company said it also received $500,000 in equity financing…

    Published on 1/9/2017
  • Loxo completes follow-on

    Loxo raised $120 million through the sale of 3.9 million shares at $31 in a follow-on underwritten by Morgan Stanley, Citigroup and Cowen.Loxo Oncology Inc. (NASDAQ:LOXO), Stamford, Conn.

    Published on 1/9/2017
  • Mirati completes follow-on

    Mirati raised $65 million through the sale of 4.4 million shares at $5.60 and 7.3 million pre-funded warrants at $5.599 in a follow-on underwritten by Leerink. The pre-funded warrants are exercisable at $0.001.Mirati …

    Published on 1/9/2017
  • Molecular Stethoscope completes venture financing

    Molecular Stethoscope raised $8.2 million in a seed financing from Data Collective, Pfizer Inc., Index Ventures, a U.S. university and individual investors.Molecular Stethoscope Inc., San Diego, Calif.

    Published on 1/9/2017
  • Neon completes venture financing

    Neon raised $70 million in a series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures and Nextech Invest joined existing investors Third Rock Ventures and…

    Published on 1/9/2017
  • NeRRe Therapeutics completes venture financing

    NeRRe raised 23 million ($28.4 million) in a series B round co-led by new investors Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed. Advent Life Sciences, Novo A/S and existing investors also …

    Published on 1/9/2017
  • Oncobiologics completes private placement of convertible notes and warrants

    Oncobiologics raised $8.4 million through the sale of 5% senior secure promissory notes in an initial close of a planned $10 million private placement with accredited investors. The notes mature on Dec. 22. Investors …

    Published on 1/9/2017
  • Owlstone completes venture financing

    Owlstone raised $11.6 million in a venture round from existing investors.Owlstone Medical Ltd., Cambridge, U.K.

    Published on 1/9/2017
  • Pionyr Immunotherapeutics completes venture financing

    Pionyr raised $8 million in a series A-1 round led by OrbiMed and SV Life Sciences. Osage University Partners, Mission Bay Ventures and private angel investors also participated.Pionyr Immunotherapeutics Inc., San …

    Published on 1/9/2017
  • Satsuma completes venture financing

    Satsuma raised $12 million in a series A round co-led by RA Capital Management and TPG Biotech.Satsuma Pharmaceuticals Inc., San Francisco, Calif.

    Published on 1/9/2017
  • scPharmaceuticals completes venture financing

    scPharmaceuticals raised $45.6 million in a series B round co-led by OrbiMed and Sun Pharmaceutical Industries Ltd. Existing investors 5AM Ventures and Lundbeckfond Ventures also participated.scPharmaceuticals Inc., …

    Published on 1/9/2017
  • Synthego completes venture financing

    Synthego raised $41 million in a series B round led by 8VC. New investors AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Real Estate Equities, ZhenFund and individual investors joined existing investors …

    Published on 1/9/2017
  • Vir Biotechnology completes venture financing

    Vir Biotechnology raised an undisclosed amount in a venture round led by Arch Venture Partners, which committed $150 million, and the Bill & Melinda Gates Foundation. Other investors include sovereign wealth funds, …

    Published on 1/9/2017
  • Handa Pharmaceuticals financial update

    Handa Pharmaceuticals began the formal process to list on the Taipei Exchange in Taiwan by applying as an emerging stock on the exchange. The company began trading as an emerging stock on Dec. 28, 2016. To obtain a …

    Published on 1/9/2017
  • Hatteras financial update

    Hatteras closed its Hatteras Venture Partners V fund with more than $150 million. It plans to invest in therapeutics, devices, diagnostics and healthcare IT companies, with a portion allocated to its Hatteras Discovery …

    Published on 1/9/2017

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993